Continuous Processing In Biomanufacturing: Considerations For Adoption And Case Studies In Biologic Development And Manufacturing

Current state-of-the-art continuous manufacturing technologies are being developed and implemented to manufacture a wide variety of products including monoclonal antibodies, recombinant proteins, and other biological modalities. Though upstream fed batch and perfusion bioreactors unit processes are relatively mature, downstream process unit operations are less mature.

Click here to download executive summary.